NCT01221909

Tranexamic Acid in Dacryocystorhinostomy

Single Dose Tranexamic Acid for Dacryocystorhinostomy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: HaEmek Medical Center, Israel · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Single dose tranexamic acid (TA) before dacryocystorhinostomy (DCR) operation: a prospective, double blind, placebo controlled study. The study hypothesis: TA in DCR might reduce the intraoperative and postoperative bleeding in DCR surgery, and might reduce the duration of the surgery.

Conditions

• Nasolacrimal Tract Obstruction

Interventions

Type	Name	Description
DRUG	Tranexamic acid	Single dose TA 500mg or placebo will be given in DCR surgery right after the first surgical incision.
DRUG	saline solution	5cc saline solution

Timeline

• Start date: 2010-12-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2010-10-15
• Last updated: 2010-10-15

Locations

1 site across 1 country: Israel